Theranos's Holmes Banned | GenomeWeb

Regulators have barred Theranos CEO Elizabeth Holmes from owning or operating a clinical lab for at least two years, the Wall Street Journal reports. The Centers for Medicare & Medicaid Services has also revoked its regulatory approval of the company's California lab and there will be a monetary penalty.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.